First Report®
- Tue, 12/21/10 - 12:55pm
- 0 Comments
- 924 reads
American Society of Consultant Pharmacists (ASCP) 2010 Annual Meeting and Exhibition
November 10-12, 2010; Orlando, FL
Posters
Falls Prevention Program Reduces Falls among Psychiatrically Ill SNF Residents
First Report®
- Mon, 11/15/10 - 11:36am
- 0 Comments
- 672 reads
American Academy of Pain Management (AAPM) 21st Annual Clinical Meeting
Las Vegas, NV; September 21-24, 2010
Posters
Duloxetine shown to reduce DPNP for 6 months
First Report®
- Mon, 10/18/10 - 2:06pm
- 0 Comments
- 675 reads
2010 Joint Annual Meeting of the International Continence Society (ICS0 and International Urogynecological Association (IUGA)
Posters
Prompt recognition and treatment of micturition disorders improves stroke outcomes
First Report®
- Thu, 9/16/10 - 4:04pm
- 0 Comments
- 1631 reads
The National Association Directors of Nursing Administration/LTC Conference
Atlanta, GA; June 12-16, 2010
Optimizing Management of COPD with Formoterol Fumarate in LTC
First Report®
- Tue, 8/24/10 - 10:55am
- 0 Comments
- 1947 reads
American Academy of Neurology 2010 Annual Meeting
Toronto, Canada; April 10-17, 2010
Poster
Nursing Home Residents with Epilepsy Present Challenges
First Report®
- Tue, 6/15/10 - 2:14pm
- 0 Comments
- 1803 reads
American Geriatrics Society 2010 Annual Scientific Meeting
Orlando, FL; May 12-15, 2010
Managing Atrial Fibrillation in the Older Patient
First Report®
- Thu, 5/20/10 - 2:52pm
- 0 Comments
- 1808 reads
American Association for Geriatric Psychiatry 2010 Annual Meeting
Savannah, GA; March 5-8, 2010
Poster
Effects of Rivastigmine Transdermal Patch on Cognitive Ability in Patients with Mild-to-Moderately Severe AD
Savannah, GA—In their study examining the specific effects of rivastigmine on individual Alzheimer’s Disease Assessment Scale-Cognitive subscale (ADAS-Cog) items and cognitive domain scores, George T. Grossberg, MD, St. Louis University School of Medicine, St. Louis, MO, and colleagues found that the rivastigmine patch is associated with improved co
First Report®
- Thu, 4/15/10 - 10:32am
- 0 Comments
- 2073 reads
American Medical Directors Association Long-Term Care Medicine 2010
Long Beach, CA; March 11-14, 2010
Poster
The Effect of Medicare Part D on Patients with Parkinson’s Disease
Long Beach, CA--It is estimated that 3% of the U.S. population age 65 and over are affected by Parkinson's disease (PD). Many patients with PD are enrolled in Medicare Part D (MPD), a prescription drug coverage program for seniors established by the Medicare Modernization Act of 2003. The Standard Benefit of Part D includes a gap in coverage, commonly known as the doughnut hole (DH). The
American Epilepsy Society 63rd Annual Meeting
- Fri, 3/19/10 - 1:43pm
- 0 Comments
- 3374 reads
Poster
Long-Term Safety and Tolerability of Lacosamide for Partial-Onset Seizures
Boston, MA—The purpose of this study, presented as a poster at the annual AES meeting, was to examine the long-term safety of lacosamide (LCM) for partial-onset seizures based on all available data from Phase II-III double-blind and open-label extension trials. William Rosenfeld, MD, of the Comprehensive Epilepsy Care Center for Children and Adults, St. Louis, MO, and colleagues found that long-term LCM treatment was generally well tolerated in their analysis of 1327 patients exposed to LCM
First Report®
- Fri, 2/19/10 - 12:14pm
- 0 Comments
- 1624 reads
Infectious Diseases Society of America 47th Annual Meeting
October 29-November 1, 2009; Philadelphia, PA
POSTER
Clinical Experience with Daptomycin for the Treatment of Patients with Bacteremic Skin and Skin-Structure Infections
Philadelphia, PA—Data from the Cubicin® Outcomes Registry and Experience (CORE) 2005-2008, a retrospective, multicenter, observational chart review to assess characteristics and clinical outcome of patients receiving daptomycin, support the use of daptomycin for skin and skin structure infections (SSSI) bacteremia (BSI). Researche
